点评： 25H1 营收稳健增长，利润增速靓丽 机构：国元证券 研究员：李典/徐梓童 事件： 公司发布2025 年半年报。 主品牌韩束Q2 增长提速，第二品牌newpage 延续倍式增长分品牌来看，主力品牌韩束25H1 实现收入 33.44 亿元，同比增长14.3%，红蛮腰全渠道累计销售1500 万套，X 肽系列累计销售破2 亿，多品类策 略成效显著，洁面膏、洗发水等新品在抖音细分品类登顶。第二曲线newpage营收3.97 亿元，同比增长 146.5%，达成2024 年全年销售额，婴童安心霜等单品在天猫细分市场表现突出。一叶子实现收入0.89 亿元，同比下降29.0%，仍处于战略调整期；红色小象实现收入1.59 亿元，同比下降8.7%，战略调整初 见成效，跌幅收窄。分品类来看，公司在护肤品品类布局敏感肌护肤品牌安敏优，25H1 推出定位光白 抗衰的中高端护肤品牌聚光白，筹备推出高端抗衰护肤品牌TAZU；母婴方面，公司筹备推出已授权知 名IP 的同名母婴品牌面包超人及奥特曼；彩妆方面，25H1 公司与彩妆师共同创立的彩妆品牌NAN beauty 上市，并正筹备推出与知名化妆造型师共同创立的彩妆品牌单彩。 线上加 ...

Industry Overview - The beauty industry is witnessing significant developments, including financial reports from various companies and the successful registration of new raw materials like Ursolic Acid [1] - Major brands are launching new products and entering new markets, indicating a dynamic and evolving landscape [1] Company Performance - Up Beauty reported a record revenue of 4.108 billion yuan for the first half of 2025, a year-on-year increase of 17.3%, with a net profit of 556 million yuan, up 34.7% [2] - Giant Biological achieved a revenue of 3.113 billion yuan in the first half of 2025, reflecting a 22.5% year-on-year growth, with a net profit of 1.182 billion yuan, up 20.6% [21] - Huaxi Biological reported a revenue of 2.261 billion yuan, with net profit figures showing no growth, but signs of strategic adjustments beginning to take effect [22] - Marubi Biological's revenue for the first half of 2025 reached 1.769 billion yuan, a 30.83% increase year-on-year, with a net profit of 186 million yuan, up 5.21% [23] New Product Developments - Up Beauty is preparing to launch a new makeup brand called "Dan Cai" in collaboration with a renowned makeup artist [2] - COSMAX announced breakthroughs in anti-aging and whitening products, including a new NAD-based anti-aging cosmetic and a new whitening powder [3] - LV Cosmetics has begun global pre-sales, indicating a strong push into the market [15] Executive Changes - Proya appointed new executives, including Xue Xia as the board secretary and Guo Xiao as the Chief Marketing Officer, both bringing extensive experience in the consumer sector [4] - Givaudan announced a leadership change, with Gilles Andrier stepping down as CEO in March 2026, to be succeeded by Christian Stammkoetter [5] Market Trends - The beauty and skincare market saw sales of 235.23 billion yuan in the first half of 2025, a 10.1% year-on-year increase, with anti-aging products showing a significant growth of 30.3% [24] - The introduction of innovative products and strategic partnerships, such as COSMAX's collaboration with Korea University for climate-proof cosmetics, reflects the industry's adaptability to changing consumer needs [15]

Core Viewpoint - The company reported strong performance for H1 2025, with revenue of 4.11 billion yuan, a year-on-year increase of 17.3%, and a net profit of 560 million yuan, up 34.7% year-on-year, falling within the upper range of previous forecasts [1][2]. Revenue Breakdown - The multi-brand matrix continues to grow, with online revenue increasing by 20.1% year-on-year in H1 2025. By brand, revenue for 韩束, Newpage 一页, 红色小象, 一叶子, and other brands were 3.34 billion, 400 million, 160 million, 90 million, and 120 million yuan respectively, with year-on-year changes of +14.3%, +146.5%, -8.7%, -29.0%, and +2.9% [1]. - By channel, online and offline revenues were 3.81 billion and 270 million yuan respectively, with year-on-year changes of +20.1% and -10.6% [1]. - By segment, skincare, maternal and infant care, and other categories generated revenues of 3.42 billion, 560 million, and 130 million yuan respectively, with year-on-year changes of +10.2%, +65.0%, and +124.3% [1]. Profitability Metrics - The net profit margin increased by 1.7 percentage points year-on-year to 13.5%. The gross margin for H1 2025 was 75.5%, down 1 percentage point year-on-year, while the expense ratio was 63.2%, up 0.03 percentage points [2]. Brand Performance - The main brand 韩束 showed steady growth, maintaining the top position in beauty brands on Douyin, with GMV growth of +15.5% on Douyin and +26.1% on Tmall. Star products like 红蛮腰 sold over 15 million units, and the X 肽 series generated over 200 million yuan in sales [2]. - The Newpage 一页 brand rapidly expanded, targeting skincare products for ages 0-18, with significant sales during the 618 shopping festival, achieving GMV growth of +190% on Douyin and +106% on Tmall [2]. Brand Portfolio Expansion - The company has a robust pipeline of brands across multiple segments, including a sensitive skin care brand in collaboration with 昆药集团, a high-end skincare brand 聚光白, and a high-end anti-aging brand TAZU. Additionally, it is preparing to launch IP co-branded products in maternal and infant care and new hair care and makeup brands [3]. Profit Forecast and Investment Rating - The company is expected to achieve net profits of 1.11 billion, 1.41 billion, and 1.76 billion yuan for 2025-2027, representing year-on-year growth of 42.3%, 26.5%, and 24.8% respectively. The latest closing price corresponds to PE ratios of 30, 24, and 19 times for the respective years, maintaining a "buy" rating [3].

Core Viewpoint - The company reported strong revenue and profit growth for the first half of 2025, with a 17.3% increase in revenue and a 30.6% increase in net profit attributable to shareholders, indicating robust operational performance and market positioning [1][2]. Financial Performance - The company achieved a revenue of 4.11 billion RMB and a net profit of 520 million RMB in the first half of 2025, with an EPS of 1.32 RMB [1]. - The gross margin decreased by 1 percentage point to 75.5%, while the expense ratio remained stable at 63.2% [2]. - Inventory increased by 7.2% year-on-year to 680 million RMB, with inventory turnover days decreasing by 5 days to 249 days [2]. - Operating net cash flow grew significantly by 77.5% to 390 million RMB [2]. Brand and Product Development - The main brand, Han Shu, maintained its leading position on the Douyin platform, ranking first among beauty brands and expanding its product line with new offerings [3]. - The company is actively pursuing a multi-brand strategy, launching new brands in various categories, including skincare, maternal and infant care, and cosmetics [3]. - New brands such as An Min You for sensitive skin and a high-end anti-aging brand TAZU are in development, alongside collaborations with well-known IPs for maternal and infant products [3]. Market Strategy and Outlook - The company is expected to benefit from its multi-brand strategy, which is anticipated to inject new growth momentum and enhance operational efficiency and profit margins [4]. - Profit forecasts for 2025, 2026, and 2027 have been adjusted upward to 1.16 billion RMB, 1.47 billion RMB, and 1.83 billion RMB, respectively, reflecting confidence in the company's growth trajectory [4].